Literature DB >> 30324536

Insulin-like growth factor-I is required to maintain muscle volume in adult mice.

Satoshi Nakamura1, Yuiko Sato1,2, Tami Kobayashi1,3, Takatsugu Oike1, Yosuke Kaneko1, Kana Miyamoto1, Atsushi Funayama1, Akihito Oya1, Toru Nishiwaki1, Morio Matsumoto1, Masaya Nakamura1, Arihiko Kanaji4, Takeshi Miyamoto5,6.   

Abstract

Insulin-like growth factor-I (IGF-I) is a peptide with diverse functions, among them regulation of embryonic development and bone homeostasis. Serum IGF-I levels decline in the elderly; however, IGF-I function in adults has not been clearly defined. Here, we show that IGF-I is required to maintain muscle mass in adults. We crossed Igf-I flox'd and Mx1 Cre mice to yield Mx1 Cre/Igf-Iflox/flox (IGF-I cKO) mice, and deleted Igf-I in adult mice by polyIpolyC injection. We demonstrate that, although serum IGF-I levels significantly decreased after polyIpolyC injection relative to (Igf-Iflox/flox) controls, serum glucose levels were unchanged. However, muscle mass decreased significantly after IGF-I down-regulation, while bone mass remained the same. In IGF-I cKO muscle, expression of anabolic factors such as Eif4e and p70S6K significantly decreased, while expression of catabolic factors MuRF1 and Atrogin-1 was normal and down-regulated, respectively, suggesting that observed muscle mass reduction was due to perturbed muscle metabolism. Our data demonstrate a specific role for IGF-I in maintaining muscle homeostasis in adults.

Entities:  

Keywords:  Adult; Aging; Insulin-like growth factor-I; Muscle wasting

Mesh:

Substances:

Year:  2018        PMID: 30324536     DOI: 10.1007/s00774-018-0964-6

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  37 in total

1.  Conditional deletion of insulin-like growth factor-I in collagen type 1alpha2-expressing cells results in postnatal lethality and a dramatic reduction in bone accretion.

Authors:  Kristen E Govoni; Jon E Wergedal; Lore Florin; Peter Angel; David J Baylink; Subburaman Mohan
Journal:  Endocrinology       Date:  2007-08-23       Impact factor: 4.736

2.  [Gas chromatographic determination of some imidazolines in pharmaceutical preparations using the FFAP in stationary phase].

Authors:  M Massaccesi
Journal:  Pharm Acta Helv       Date:  1987

3.  Calf haematoma: a new sign in differential diagnosis from deep vein thrombosis.

Authors:  D A Tibbutt; A J Gunning
Journal:  Br Med J       Date:  1974-10-26

4.  Phenotypic alterations in insulin-deficient mutant mice.

Authors:  B Duvillié; N Cordonnier; L Deltour; F Dandoy-Dron; J M Itier; E Monthioux; J Jami; R L Joshi; D Bucchini
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

Review 5.  Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectives.

Authors:  Roland Baron; Eric Hesse
Journal:  J Clin Endocrinol Metab       Date:  2012-01-11       Impact factor: 5.958

6.  Osteoblast-Specific Loss of IGF1R Signaling Results in Impaired Endochondral Bone Formation During Fracture Healing.

Authors:  Tao Wang; Yongmei Wang; Alicia Menendez; Chak Fong; Muriel Babey; Candice G T Tahimic; Zhiqiang Cheng; Alfred Li; Wenhan Chang; Daniel D Bikle
Journal:  J Bone Miner Res       Date:  2015-09       Impact factor: 6.741

Review 7.  Somatotropic signaling: trade-offs between growth, reproductive development, and longevity.

Authors:  Andrzej Bartke; Liou Y Sun; Valter Longo
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

8.  Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r).

Authors:  J P Liu; J Baker; A S Perkins; E J Robertson; A Efstratiadis
Journal:  Cell       Date:  1993-10-08       Impact factor: 41.582

Review 9.  Insulin-like growth factor binding-protein-3 (IGFBP-3).

Authors:  Michael B Ranke
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2015-06-27       Impact factor: 4.690

10.  Conditional deletion of IGF-I in osteocytes unexpectedly accelerates bony union of the fracture gap in mice.

Authors:  Kin-Hing W Lau; Charles H Rundle; Xiao-Dong Zhou; David J Baylink; Matilda H-C Sheng
Journal:  Bone       Date:  2016-08-09       Impact factor: 4.398

View more
  4 in total

1.  The Relationship between Serum Insulin-Like Growth Factor-1 Levels and Body Composition Changes after Sleeve Gastrectomy.

Authors:  Masahiro Ohira; Yasuhiro Watanabe; Takashi Yamaguchi; Hiroki Onda; Shuhei Yamaoka; Kazuki Abe; Shoko Nakamura; Shou Tanaka; Naoyuki Kawagoe; Taiki Nabekura; Atsuhito Saiki; Takashi Oshiro; Daiji Nagayama; Ichiro Tatsuno
Journal:  Obes Facts       Date:  2021-10-14       Impact factor: 3.942

2.  A Metabolomic Profile Predictive of New Osteoporosis or Sarcopenia Development.

Authors:  Kana Miyamoto; Akiyoshi Hirayama; Yuiko Sato; Satsuki Ikeda; Midori Maruyama; Tomoyoshi Soga; Masaru Tomita; Masaya Nakamura; Morio Matsumoto; Noriko Yoshimura; Takeshi Miyamoto
Journal:  Metabolites       Date:  2021-04-28

3.  Vitamin D protects against immobilization-induced muscle atrophy via neural crest-derived cells in mice.

Authors:  Satoshi Nakamura; Yuiko Sato; Tami Kobayashi; Yosuke Kaneko; Eri Ito; Tomoya Soma; Hiroyuki Okada; Kana Miyamoto; Akihito Oya; Morio Matsumoto; Masaya Nakamura; Arihiko Kanaji; Takeshi Miyamoto
Journal:  Sci Rep       Date:  2020-07-22       Impact factor: 4.379

4.  Oral administration of N-acetyl cysteine prevents osteoarthritis development and progression in a rat model.

Authors:  Yosuke Kaneko; Nobuharu Tanigawa; Yuiko Sato; Tami Kobayashi; Satoshi Nakamura; Eri Ito; Tomoya Soma; Kana Miyamoto; Shu Kobayashi; Kengo Harato; Morio Matsumoto; Masaya Nakamura; Yasuo Niki; Takeshi Miyamoto
Journal:  Sci Rep       Date:  2019-12-10       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.